Literature DB >> 12684481

Glucagon-like peptide-1-responsive catecholamine neurons in the area postrema link peripheral glucagon-like peptide-1 with central autonomic control sites.

Hiroshi Yamamoto1, Toshiro Kishi, Charlotte E Lee, Brian J Choi, Hui Fang, Anthony N Hollenberg, Daniel J Drucker, Joel K Elmquist.   

Abstract

Glucagon-like peptide-1 (GLP-1) released from the gut is an incretin that stimulates insulin secretion. GLP-1 is also a brain neuropeptide that has diverse central actions, including inhibition of food and water intake, gastric emptying, and stimulation of neuroendocrine responses characteristic of visceral illness. Both intravenous and intracerebroventricular administration of GLP-1 receptor (GLP-1R) agonists increase blood pressure and heart rate and induce Fos-like immunoreactivity (Fos-IR) in autonomic regulatory sites in the rat brain. The area postrema (AP) is a circumventricular organ and has been implicated in processing visceral sensory information. GLP-1Rs are densely expressed in the AP, and peripheral GLP-1R agonists induce Fos-IR in AP neurons to a greater degree than intracerebroventricular administration. Because the AP lacks a blood-brain barrier, we hypothesized that the AP is a key site for peripheral GLP-1 to activate central autonomic regulatory sites. In this study, we found that many tyrosine hydroxylase (TH)-containing neurons in the AP expressed GLP-1Rs and Fos-IR after intravenous GLP-1R agonists. Furthermore, intravenous but not intracerebroventricular GLP-1R agonists induced TH transcription in the AP in vivo. In addition, GLP-1R agonists directly activated TH transcription in an in vitro cell system. Finally, we found that GLP-1-responsive TH neurons in the AP innervate autonomic control sites, including the parabrachial nucleus, nucleus of solitary tract, and ventrolateral medulla. These findings suggest that catecholamine neurons in the AP link peripheral GLP-1 and central autonomic control sites that mediate the diverse neuroendocrine and autonomic actions of peripheral GLP-1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12684481      PMCID: PMC6742071     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  55 in total

1.  Neural contribution to the effect of glucagon-like peptide-1-(7-36) amide on arterial blood pressure in rats.

Authors:  J M Barragán; J Eng; R Rodríguez; E Blázquez
Journal:  Am J Physiol       Date:  1999-11

2.  Cell-specific localization of G protein alpha-subunits in the islets of Langerhans.

Authors:  G Skoglund; A Basmaciogullari; B Rouot; J C Marie; G Rosselin
Journal:  J Endocrinol       Date:  1999-07       Impact factor: 4.286

3.  4.5 kb of the rat tyrosine hydroxylase 5' flanking sequence directs tissue specific expression during development and contains consensus sites for multiple transcription factors.

Authors:  J J Schimmel; L Crews; S Roffler-Tarlov; D M Chikaraishi
Journal:  Brain Res Mol Brain Res       Date:  1999-12-10

4.  Glucagon-like peptide 1 stimulates insulin gene promoter activity by protein kinase A-independent activation of the rat insulin I gene cAMP response element.

Authors:  G Skoglund; M A Hussain; G G Holz
Journal:  Diabetes       Date:  2000-07       Impact factor: 9.461

Review 5.  The entero-insular axis in type 2 diabetes--incretins as therapeutic agents.

Authors:  W Creutzfeldt
Journal:  Exp Clin Endocrinol Diabetes       Date:  2001       Impact factor: 2.949

6.  Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta).

Authors:  A A Young; B R Gedulin; S Bhavsar; N Bodkin; C Jodka; B Hansen; M Denaro
Journal:  Diabetes       Date:  1999-05       Impact factor: 9.461

7.  Postprandial GLP-1, norepinephrine, and reactive hypoglycemia in dumping syndrome.

Authors:  B Gebhard; J J Holst; C Biegelmayer; J Miholic
Journal:  Dig Dis Sci       Date:  2001-09       Impact factor: 3.199

8.  The role of CNS glucagon-like peptide-1 (7-36) amide receptors in mediating the visceral illness effects of lithium chloride.

Authors:  R J Seeley; K Blake; P A Rushing; S Benoit; J Eng; S C Woods; D D'Alessio
Journal:  J Neurosci       Date:  2000-02-15       Impact factor: 6.167

9.  Lipopolysaccharide activates specific populations of hypothalamic and brainstem neurons that project to the spinal cord.

Authors:  Y H Zhang; J Lu; J K Elmquist; C B Saper
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.167

10.  Transcriptional regulation of the thyrotropin-releasing hormone gene by leptin and melanocortin signaling.

Authors:  M Harris; C Aschkenasi; C F Elias; A Chandrankunnel; E A Nillni; C Bjøorbaek; J K Elmquist; J S Flier; A N Hollenberg
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

View more
  100 in total

1.  Central and peripheral administration of secretin inhibits food intake in mice through the activation of the melanocortin system.

Authors:  Carrie Yuen Yee Cheng; Jessica Yan Shuen Chu; Billy Kwok Chong Chow
Journal:  Neuropsychopharmacology       Date:  2010-10-06       Impact factor: 7.853

2.  Circulating GLP-1 and CCK-8 reduce food intake by capsaicin-insensitive, nonvagal mechanisms.

Authors:  Jingchuan Zhang; Robert C Ritter
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-10-26       Impact factor: 3.619

3.  Potential role of TCF7L2 gene variants on cardiac sympathetic/parasympathetic activity.

Authors:  Virginia Boccardi; Immacolata Ambrosino; Michela Papa; Daniela Fiore; Maria Rosaria Rizzo; Giuseppe Paolisso; Michelangela Barbieri
Journal:  Eur J Hum Genet       Date:  2010-07-21       Impact factor: 4.246

Review 4.  Dumping Syndrome: A Review of the Current Concepts of Pathophysiology, Diagnosis, and Treatment.

Authors:  Patrick Berg; Richard McCallum
Journal:  Dig Dis Sci       Date:  2015-09-22       Impact factor: 3.199

Review 5.  GLP-1 Agonists and Blood Pressure: A Review of the Evidence.

Authors:  Aditya Goud; Jixin Zhong; Matthew Peters; Robert D Brook; Sanjay Rajagopalan
Journal:  Curr Hypertens Rep       Date:  2016-02       Impact factor: 5.369

6.  A possible role of GLP-1 in the pathophysiology of early dumping syndrome.

Authors:  Hiroshi Yamamoto; Tsuyoshi Mori; Hiroshi Tsuchihashi; Hiroya Akabori; Hiroyuki Naito; Tohru Tani
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

7.  Characterization of Kiss1 neurons using transgenic mouse models.

Authors:  R M Cravo; L O Margatho; S Osborne-Lawrence; J Donato; S Atkin; A L Bookout; S Rovinsky; R Frazão; C E Lee; L Gautron; J M Zigman; C F Elias
Journal:  Neuroscience       Date:  2010-11-18       Impact factor: 3.590

8.  Suppression of food intake by glucagon-like peptide-1 receptor agonists: relative potencies and role of dipeptidyl peptidase-4.

Authors:  Lene Jessen; Benedikt A Aulinger; Jonathan L Hassel; Kyle J Roy; Eric P Smith; Todd M Greer; Stephen C Woods; Randy J Seeley; David A D'Alessio
Journal:  Endocrinology       Date:  2012-10-02       Impact factor: 4.736

Review 9.  The role of incretins in glucose homeostasis and diabetes treatment.

Authors:  Wook Kim; Josephine M Egan
Journal:  Pharmacol Rev       Date:  2008-12-12       Impact factor: 25.468

10.  Preproglucagon Neurons in the Nucleus of the Solitary Tract Are the Main Source of Brain GLP-1, Mediate Stress-Induced Hypophagia, and Limit Unusually Large Intakes of Food.

Authors:  Marie K Holt; James E Richards; Daniel R Cook; Daniel I Brierley; Diana L Williams; Frank Reimann; Fiona M Gribble; Stefan Trapp
Journal:  Diabetes       Date:  2018-10-02       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.